This AJMC® clinical brief summarizes pharmacologic treatment recommendations for chronic obstructive pulmonary disease (COPD) and reviews a retrospective claims-based study analyzing differences in clinical and economic outcomes with initiation of dual or triple therapy in patients with COPD.